At the request of mutual customers Bristol-Myers Squibb and Abbott, Iconix Pharmaceuticals and Rosetta BioSoftware will develop a tool that will enable Iconix's DrugMatrix data to operate on Rosetta's Resolver system, the tool vendors said last week.

As a result, researchers at the pharma giants -both of whom co-partner with Iconix- and new Rosetta and Iconix customers will now be able to convert Iconix's reference database of genomic analyses of chemical compounds into data that can be managed and analyzed on the Rosetta system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.